Ipsen Biopharmaceuticals, Inc. is a US affiliate of Ipsen SA, a global biotech company. At Ipsen Biopharmaceuticals, we are focused on developing and providing access to therapies for patients who suffer from extremely difficult-to-treat diseases. For more information on Ipsen in the United States, please visit www.ipsenus.com. To report Adverse Events to Ipsen, please call 1-855-463-5127.
Somatuline Depot (lanreotide injection) Prescribing Information »
Onivyde (irinotecan liposome injection) Prescribing Information and Blackbox warning »